DOCSLIB.ORG

Surgery of Spinal Cord Pilocytic Astrocytoma Complicated by Leptomeningeal Dissemination to the Brain and Spine and Rapid Progression

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Surgery of Spinal Cord Pilocytic Astrocytoma Complicated by Leptomeningeal Dissemination to the Brain and Spine and Rapid Progression Formosan Journal of Surgery (2013) 46,65e69 Available online at www.sciencedirect.com journal homepage: www.e-fjs.com CASE REPORT Surgery of spinal cord pilocytic astrocytoma complicated by leptomeningeal dissemination to the brain and spine and rapid progression Yu-Lin Chou a,b, Joon-Khim Loh a,b,*, Shiuh-Lin Hwang a,b a Division of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan b Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan Received 10 June 2012; received in revised form 29 August 2012; accepted 14 September 2012 Available online 6 April 2013 KEYWORDS Summary Pilocytic astrocytoma (PCA) is a common benign astrocytic tumor in children that children; usually arises in the cerebellum, brainstem, hypothalamic region, or optic pathways. It can leptomeningeal also arise in the spinal cord as an intradural intramedullary PCA. In rare cases, it presents with dissemination; leptomeningeal dissemination, which leads to a poor clinical outcome. We present a rare case pilocytic astrocytoma of spinal cord pilocytic astrocytoma with leptomeningeal dissemination to the brain and spine with rapid progression. We present a 13-year-old girl with progressive weakness of her right arm. An intramedullary hypervascular neurogenic tumor at the C3eC6 level was identified by magnetic resonance imaging (MRI) and surgical excision was performed. PCA was proven by pathology. The tumor recurred 3 months later and an intramedullary polycystic astrocytoma at the C1eT1 level was confirmed by MRI. Total tumor resection was performed and patholog- ical characteristics again confirmed PCA. However, diplopia with blurred vision was noted 1 month after the last surgery, which was accompanied by signs of increased intracranial pres- sure (IICP). MRI indicated leptomeningeal enhancement in the brain and tumor seeding along the spinal cord. Chemotherapy and radiotherapy were administered, but the clinical course rapidly deteriorated and the patient died of respiratory distress. Although the prognosis for low-grade astrocytomas is good in most reported studies, this case showed leptomeningeal dissemination with a rapid course that resulted in death. A fatal outcome might be anticipated when encountering difficult intramedullary spinal cord lesions, as in our case. Copyright ª 2013, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights reserved. * Corresponding author. Division of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, Kaohsiung 80708, Taiwan. E-mail address: safi[email protected] (J.-K. Loh). 1682-606X/$ - see front matter Copyright ª 2013, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights reserved. http://dx.doi.org/10.1016/j.fjs.2013.01.006 66 Y.-L. Chou et al. 1. Introduction Pilocytic astrocytoma (PCA) is a common astrocytic tumor in children that most commonly arises in the cerebellum, brainstem, hypothalamic region, or optic pathways.1 It can also arise from the spinal cord, which accounts for 9% of PCA cases.2 It is usually benign with a favorable outcome, although in rare cases it presents with leptomeningeal dissemination, which leads to a poor clinical outcome.3 We present a case of spinal cord intradural intramedullary PCA with leptomeningeal dissemination to the brain and spine with rapid progression. 2. Case report A 13-year-old girl presented with progressive weakness of Figure 2 Histology of the spinal cord tumor showing a her right arm that first occurred over 1 month before her biphasic pattern with compact bipolar cells and loose-textured visit. An intramedullary hypervascular neurogenic tumor at multipolar cells with microcysts and granular bodies (hema- the C3eC6 level was identified by magnetic resonance im- toxylin and eosin stain, 40Â). aging (MRI) (Fig. 1A). Surgical resection of the tumor and an intraoperative frozen section revealed a high-grade astro- cytoma; thus, a C3eC6 laminectomy and subtotal tumor Three months later, progressive muscle weakness in the resection were performed. However, the permanent pa- patient’s right arm recurred. MRI revealed enlargement of thology report was a WHO grade I PCA that exhibited a the intramedullary astrocytoma at the C1eT1 level biphasic pattern with compact bipolar cells and loose- (Fig. 1B). A C3eT1 laminectomy and total resection of the textured multipolar cells with microcysts and granular spinal tumor were performed. Piecemeal resection of the bodies. An immunohistochemical study showed that the tumor was carried out until a clean surgical field was ob- tumor cells were GFAP-positive and EMA-negative. The Ki- tained under a microscope at the end of the procedure, and 67 labeling index was <5% (Fig. 2). a clean postoperative MRI was recorded (Fig. 1C). The Figure 1 Spinal MRI (sagittal T1-weighted MRI with gadolinium contrast) showing (A) preoperative intramedullary tumor, (B) recurrence of the intramedullary astrocytoma from the cervical to the thoracic level, (C) total removal of the tumor after the second surgery, (D) leptomeningeal enhancement at the cervical level extended to the cauda equina, and (E) tumor seeding in the central canal with related syringomyelia at C2eC6 with (F) worsening of leptomeningeal metastases at the upper T spine level. Spinal cord PCA with brain & spine dissemination 67 pathology report was still PCA and radiotherapy was carried leptomeningeal metastases at the upper T spine level out because of the rapid recurrence. (Fig. 1E and F). Only 1 month after the last surgery, the patient expe- Because of the poor response, the chemotherapeutic rienced diplopia with blurred vision, which was accompa- agent was changed to temozolomide, and then to cyclo- nied by dizziness, headache, and poor appetite. MRI of the phosphamide and mesna. Disturbance of consciousness brain showed some leptomeningeal enhancement around occurred with frequent seizures after 1 month of treat- the brain stem and suspicion of seeding (Fig. 3A and B). ment. A repeat brain MRI showed multiple enlarged nodules Spinal MRI showed that leptomeningeal enhancement at in the cerebellum, the left medial temporal lobe, the right the cervical level had extended to the cauda equina temporal horn, and the right insula, and diffuse involve- (Fig. 1D). ment along the cerebral and cerebellar leptomeninges Because of the leptomeningeal dissemination to the (Fig. 3C and D). The patient then developed respiratory brain and spine, chemotherapy with vincristine and carbo- distress and no further treatment was administered in platin was administered. However, the patient’s visual accordance with the wishes of her family members. She defect progressed to near-blindness after 3 weeks of died 1 week later after a total clinical course of less than 9 treatment. Another brain MRI revealed worsening of the months. leptomeningeal enhancement around the brain stem and multiple enhancing lesions at the rostrum of the left corpus callosum, third ventricle, both superior cerebellar pedun- 3. Discussion cles, and both cerebellar hemispheres. The weakness of the patient’s right arm also recurred, PCAs are benign and slow-growing, with a high rate of cure along with a feeling of numbness. Another MRI of the C-T after resection3; some 9% of these are found to be intra- spine revealed tumor seeding in the central canal with medullary.2 Tumor cell dissemination within the cerebro- related syringomyelia at C2eC6 and worsening of spinal fluid (CSF) has primarily been reported for malignant Figure 3 Brain MRI (axial T1-weighted MRI with gadolinium contrast) showing (A, B) leptomeningeal enhancement around the brain stem and cerebellar hemispheres and (C, D) multiple enlarged nodules in the cerebellum, the left medial temporal lobe, the right temporal horn, the right insular lobe, and diffuse involvement along the cerebral and cerebellar leptomeninges. 68 Y.-L. Chou et al. Table 1 Spinal WHO grade I PCA with leptomeningeal dissemination. Study Age Sex Initial symptoms Primary Time to Recurrent symptoms Tumor spread (y) location recurrence Ng et al4 9 F Progressive C5eC7 2.5 y (brain) Occipital headaches, Sylvian fissures, paraparesis vomiting, slurring of brainstem, speech, generalized cerebellar sulci toniceclonic convulsion Abel et al6 4 M Unsteadiness C7eT10 6 mo (spine) Decreasing bilateral Cisternal space and loss of 2.5 y (brain) leg function of midbrain, balance suprasellar space, auditory canal Our case 13 F Progressive right C3eC6 3 mo (spine) Right arm weakness, Cerebellum, left arm weakness 4 mo (brain) diplopia, blurred vision, medial temporal lobe, dizziness, headache, right temporal horn, poor appetite, limb right insular lobe, weakness cerebral and cerebellar leptomeninges, C2eC6, T11e12, L1e5 tumors, although it has also been observed in a few cases of chemotherapy regimen with carboplatin and vincristine,6 and PCA,4 and in most of these cases the tumor was intracra- both remained in a stable condition. However, radiotherapy nial.5 A review of the literature shows only two cases of and chemotherapy provided no benefits for our patient and intramedullary WHO grade I PCA associated with lep- the leptomeningeal dissemination progressed rapidly. tomeningeal dissemination (Table 1).4,6 The most common areas of leptomeningeal dissemina- tion are the Sylvian fissures, basilar cisterns, and cauda 4. Conclusion equina, in which a slower rate of CSF flow and gravity may contribute to this phenomenon.6 In the present case, the We described
Load more

Recommended publications
  • Vetp-42-06-Brief Communications
    Veterinary Pathology Online http://vet.sagepub.com/ Primitive Neuroectodermal Tumor in the Spinal Cord of a Brahman Crossbred Calf A. Berrocal, D. L. Montgomery, J. T. Mackie and R. W. Storts Vet Pathol 2005 42: 834 DOI: 10.1354/vp.42-6-834 The online version of this article can be found at: http://vet.sagepub.com/content/42/6/834 Published by: http://www.sagepublications.com On behalf of: American College of Veterinary Pathologists, European College of Veterinary Pathologists, & the Japanese College of Veterinary Pathologists. Additional services and information for Veterinary Pathology Online can be found at: Email Alerts: http://vet.sagepub.com/cgi/alerts Subscriptions: http://vet.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav Downloaded from vet.sagepub.com by guest on December 25, 2010 834 Brief Communications and Case Reports Vet Pathol 42:6, 2005 Vet Pathol 42:834–836 (2005) Primitive Neuroectodermal Tumor in the Spinal Cord of a Brahman Crossbred Calf A. BERROCAL,D.L.MONTGOMERY,J.T.MACKIE, AND R. W. STORTS Abstract. A variety of embryonal tumors of the central nervous system, typically malignant and occurring in young individuals, are recognized in humans and animals. This report describes an invasive subdural but predominantly extramedullary primitive neuroectodermal tumor developing at the lumbosacral junction in a 6-month-old Brahman crossbred calf. The tumor was composed of spindloid embryonal cells organized in interlacing fascicles. The cells had oval to elongate or round hyperchromic nuclei, single to double nucleoli, and scant discernible cytoplasm. Immunohistochemical staining for neuron-specific enolase, synaptophysin, and S-100 protein and formation of pseudorosettes suggested neuronal and possibly ependymal differentiation.
    [Show full text]
  • Leptomeningeal Dissemination of Pilocytic Astrocytoma Via Hematoma in a Child
    Neurosurg Focus 13 (1):Clinical Pearl 2, 2002, Click here to return to Table of Contents Leptomeningeal dissemination of pilocytic astrocytoma via hematoma in a child Case report MASARU KANDA, M.D., HIDENOBU TANAKA, M.D., PH.D., SOJI SHINODA, M.D., PH.D., AND TOSHIO MASUZAWA, M.D., PH.D. Department of Surgical Neurology, Jichi Medical School, Tochigi, Japan A case of recurrent pilocytic astrocytoma with leptomeningeal dissemination (LMD) is described. A cerebellar tumor was diagnosed in a 3-year-old boy, in whom resection was performed. When the boy was 6 years of age, recur- rence was treated with surgery and local radiotherapy. At age 13 years, scoliosis was present, but the patient was asymptomatic. Twelve years after initial surgery LMD was demonstrated in the lumbar spinal region without recur- rence of the original tumor. This tumor also was subtotally removed. During the procedure, a hematoma was observed adjacent to the tumor, but the border was clear. Histological examination of the spinal cord tumor showed features sim- ilar to those of the original tumor. There were no tumor cells in the hematoma. The MIB-1 labeling index indicated no malignant change compared with the previous samples. Radiotherapy was performed after the surgery. The importance of early diagnosis and management of scoliosis is emphasized, and the peculiar pattern of dissemination of the pilo- cytic astrocytoma and its treatment are reviewed. KEY WORDS • pilocytic astrocytoma • leptomeningeal dissemination • MIB-1 labeling index • radiation therapy • scoliosis
    [Show full text]
  • Central Nervous System
    PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM LOW GRADE GLIOMAS CNS Site Group – Low Grade Gliomas Author: Dr. Norm Laperriere 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND EARLY DETECTION 3 4. DIAGNOSIS AND PATHOLOGY 3 5. MANAGEMENT 4 5.1 MANAGEMENT ALGORITHMS 4 5.2 SURGERY 4 5.3 CHEMOTHERAPY 5 5.4 RADIATION THERAPY 5 6. ONCOLOGY NURSING PRACTICE 6 7. SUPPORTIVE CARE 6 7.1 PATIENT EDUCATION 6 7.2 PSYCHOSOCIAL CARE 6 7.3 SYMPTOM MANAGEMENT 6 7.4 CLINICAL NUTRITION 7 7.5 PALLIATIVE CARE 7 7.6 REHABILITATION 7 8. FOLLOW-UP CARE 7 Last Revision Date – April 2019 2 Low Grade Gliomas 1. Introduction • Grade I gliomas: pilocytic astrocytoma (PA), dysembryoplastic neuroepithelial tumor (DNET), pleomorphic xanthoastrocytoma, (PXA), ganglioglioma • Grade II gliomas: infiltrating astrocytoma, oligodendroglioma, mixed gliomas • annual incidence is approx. 1/100,000 This document is intended for use by members of the Central Nervous System site group of the Princess Margaret Hospital/University Health Network. The guidelines in this document are meant as a guide only, and are not meant to be prescriptive. There exists a multitude of individual factors, prognostic factors and peculiarities in any individual case, and for that reason the ultimate decision as to the management of any individual patient is at the discretion of the staff physician in charge of that particular patient’s care. 2. Prevention • genetic counseling for all NF1 carriers 3. Screening and Early Detection • baseline MRI brain for all newly
    [Show full text]
  • Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)
    Last updated: 3/4/2021 Prepared by Kurt Schaberg Central Nervous System Tumors General ~1% of tumors in adults, but ~25% of malignancies in children (only 2nd to leukemia). Significant increase in incidence in primary brain tumors in elderly. Metastases to the brain far outnumber primary CNS tumors→ multiple cerebral tumors. One can develop a very good DDX by just location, age, and imaging. Differential Diagnosis by clinical information: Location Pediatric/Young Adult Older Adult Cerebral/ Ganglioglioma, DNET, PXA, Glioblastoma Multiforme (GBM) Supratentorial Ependymoma, AT/RT Infiltrating Astrocytoma (grades II-III), CNS Embryonal Neoplasms Oligodendroglioma, Metastases, Lymphoma, Infection Cerebellar/ PA, Medulloblastoma, Ependymoma, Metastases, Hemangioblastoma, Infratentorial/ Choroid plexus papilloma, AT/RT Choroid plexus papilloma, Subependymoma Fourth ventricle Brainstem PA, DMG Astrocytoma, Glioblastoma, DMG, Metastases Spinal cord Ependymoma, PA, DMG, MPE, Drop Ependymoma, Astrocytoma, DMG, MPE (filum), (intramedullary) metastases Paraganglioma (filum), Spinal cord Meningioma, Schwannoma, Schwannoma, Meningioma, (extramedullary) Metastases, Melanocytoma/melanoma Melanocytoma/melanoma, MPNST Spinal cord Bone tumor, Meningioma, Abscess, Herniated disk, Lymphoma, Abscess, (extradural) Vascular malformation, Metastases, Extra-axial/Dural/ Leukemia/lymphoma, Ewing Sarcoma, Meningioma, SFT, Metastases, Lymphoma, Leptomeningeal Rhabdomyosarcoma, Disseminated medulloblastoma, DLGNT, Sellar/infundibular Pituitary adenoma, Pituitary adenoma,
    [Show full text]
  • Radiation Oncology Guidelines
    National Imaging Associates, Inc.* 2021 Magellan Clinical Guidelines For Medical Necessity Review RADIATION ONCOLOGY GUIDELINES Effective January 1, 2021 – December 31, 2021 *National Imaging Associates, Inc. (NIA) is a subsidiary of Magellan Healthcare, Inc. Copyright © 2019-2020 National Imaging Associates, Inc., All Rights Reserved Guidelines for Clinical Review Determination Preamble Magellan is committed to the philosophy of supporting safe and effective treatment for patients. The medical necessity criteria that follow are guidelines for the provision of diagnostic imaging. These criteria are designed to guide both providers and reviewers to the most appropriate diagnostic tests based on a patient’s unique circumstances. In all cases, clinical judgment consistent with the standards of good medical practice will be used when applying the guidelines. Determinations are made based on both the guideline and clinical information provided at the time of the request. It is expected that medical necessity decisions may change as new evidence-based information is provided or based on unique aspects of the patient’s condition. The treating clinician has final authority and responsibility for treatment decisions regarding the care of the patient. 2021 Magellan Clinical Guidelines-Radiation Oncology 2 Guideline Development Process These medical necessity criteria were developed by Magellan Healthcare for the purpose of making clinical review determinations for requests for therapies and diagnostic procedures. The developers of the criteria sets included representatives from the disciplines of radiology, internal medicine, nursing, cardiology, and other specialty groups. Magellan’s guidelines are reviewed yearly and modified when necessary following a literature search of pertinent and established clinical guidelines and accepted diagnostic imaging practices.
    [Show full text]
  • Spinal Meningiomas: a Review
    nal of S ur pi o n J e Galgano et al., J Spine 2014, 3:1 Journal of Spine DOI: 10.4172/2165-7939.1000157 ISSN: 2165-7939 Review Rrticle Open Access Spinal Meningiomas: A Review Michael A Galgano, Timothy Beutler, Aaron Brooking and Eric M Deshaies* Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, NY, USA Abstract Meningiomas of the spinal axis have been identified from C1 to as distal as the sacrum. Their clinical presentation varies greatly based on their location. Meningiomas situated in the atlanto-axial region may present similarly to some meningiomas of the craniocervical junction, while some of the more distal spinal axis meningiomas are discovered as a result of chronic back pain. Surgical resection remains the mainstay of treatment, although advancements in radiosurgery have led to increased utilization as a primary or adjuvant therapy. Angiography also plays a critical role in surgical planning and may be utilized for preoperative embolization of hypervascular meningiomas. Keywords: Meningioma; Neurosurgery; Radiosurgery; Angiography favorable and biological outcome [11]. They also found that either a lack of estrogen and progesterone receptors, or the presence of estrogen Introduction receptors in meningiomas, correlated with a more aggressive clinical Spinal meningiomas are tumors originating from arachnoid cap behavior, progression, and recurrence. Hsu and Hedley Whyte also cells most commonly situated in the intradural extramedullary region found that the presence of progesterone receptors, even in a small [1,2]. They represent a high proportion of all spinal cord tumors. Spinal subgroup of tumor cells, indicated a more favorable prognostic value meningiomas tend to predominate in the thoracic region, although for meningiomas [12].
    [Show full text]
  • Primary Spinal Astrocytomas: a Literature Review
    Open Access Review Article DOI: 10.7759/cureus.5247 Primary Spinal Astrocytomas: A Literature Review John Ogunlade 1 , James G. Wiginton IV 1 , Christopher Elia 1 , Tiffany Odell 2 , Sanjay C. Rao 3 1. Neurosurgery, Riverside University Health System Medical Center, Moreno Valley, USA 2. Neurosurgery, Desert Regional Medical Center, Palm Springs, USA 3. Neurosurgery, Kaiser Permanente - Fontana Medical Center, Fontana, USA Corresponding author: John Ogunlade, [email protected] Abstract Primary spinal astrocytoma is a subtype of glioma, the most common spinal cord tumor found in the intradural intramedullary compartment. Spinal astrocytomas account for 6-8% of all spinal cord tumors and are primarily low grade (World Health Organization grade I (WHO I) or WHO II). They are seen in both the adult and pediatric population with the most common presenting symptoms being back pain, sensory dysfunction, or motor dysfunction. Magnetic Resonance Imaging (MRI) with and without gadolinium is the imaging of choice, which usually reveals a hypointense T1 weighted and hyperintense T2 weighted lesion with a heterogeneous pattern of contrast enhancement. Further imaging which may aid in surgical planning includes computerized tomography, diffusion tensor imaging, and tractography. Median survival in spinal cord astrocytomas ranges widely. The factors most significantly associated with poor prognosis and shorter median survival are older age at initial diagnosis, higher grade lesion based on histology, and extent of resection. The mainstay of treatment for primary spinal cord astrocytomas is surgical resection, with the goal of preservation of neurologic function, guided by intraoperative neuromonitoring. Adjunctive radiation has been shown beneficial and may increase overall survival.
    [Show full text]
  • Differentiation Between Pilocytic Astrocytoma and Glioblastoma: a Decision Tree Model Using Contrast-Enhanced Magnetic Resonance
    European Radiology (2019) 29:3968–3975 https://doi.org/10.1007/s00330-018-5706-6 ONCOLOGY Differentiation between pilocytic astrocytoma and glioblastoma: a decision tree model using contrast-enhanced magnetic resonance imaging-derived quantitative radiomic features Fei Dong1 & Qian Li1 & Duo Xu1 & Wenji Xiu2 & Qiang Zeng3 & Xiuliang Zhu1 & Fangfang Xu1 & Biao Jiang1 & Minming Zhang1 Received: 13 March 2018 /Revised: 8 July 2018 /Accepted: 6 August 2018 /Published online: 12 November 2018 # European Society of Radiology 2018 Abstract Objective To differentiate brain pilocytic astrocytoma (PA) from glioblastoma (GBM) using contrast-enhanced mag- netic resonance imaging (MRI) quantitative radiomic features by a decision tree model. Methods Sixty-six patients from two centres (PA, n = 31; GBM, n = 35) were randomly divided into training and validation data sets (about 2:1). Quantitative radiomic features of the tumours were extracted from contrast-enhanced MR images. A subset of features was selected by feature stability and Boruta algorithm. The selected features were used to build a decision tree model. Predictive accuracy, sensitivity and specificity were used to assess model performance. The classification outcome of the model was combined with tumour location, age and gender features, and multivariable logistic regression analysis and permutation test using the entire data set were performed to further evaluate the decision tree model. Results A total of 271 radiomic features were successfully extracted for each tumour. Twelve features were selected as input variables to build the decision tree model. Two features S(1, -1) Entropy and S(2, -2) SumAverg were finally included in the model. The model showed an accuracy, sensitivity and specificity of 0.87, 0.90 and 0.83 for the training data set and 0.86, 0.80 and 0.91 for the validation data set.
    [Show full text]
  • Malignant CNS Solid Tumor Rules
    Malignant CNS and Peripheral Nerves Equivalent Terms and Definitions C470-C479, C700, C701, C709, C710-C719, C720-C725, C728, C729, C751-C753 (Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140) Introduction Note 1: This section includes the following primary sites: Peripheral nerves C470-C479; cerebral meninges C700; spinal meninges C701; meninges NOS C709; brain C710-C719; spinal cord C720; cauda equina C721; olfactory nerve C722; optic nerve C723; acoustic nerve C724; cranial nerve NOS C725; overlapping lesion of brain and central nervous system C728; nervous system NOS C729; pituitary gland C751; craniopharyngeal duct C752; pineal gland C753. Note 2: Non-malignant intracranial and CNS tumors have a separate set of rules. Note 3: 2007 MPH Rules and 2018 Solid Tumor Rules are used based on date of diagnosis. • Tumors diagnosed 01/01/2007 through 12/31/2017: Use 2007 MPH Rules • Tumors diagnosed 01/01/2018 and later: Use 2018 Solid Tumor Rules • The original tumor diagnosed before 1/1/2018 and a subsequent tumor diagnosed 1/1/2018 or later in the same primary site: Use the 2018 Solid Tumor Rules. Note 4: There must be a histologic, cytologic, radiographic, or clinical diagnosis of a malignant neoplasm /3. Note 5: Tumors from a number of primary sites metastasize to the brain. Do not use these rules for tumors described as metastases; report metastatic tumors using the rules for that primary site. Note 6: Pilocytic astrocytoma/juvenile pilocytic astrocytoma is reportable in North America as a malignant neoplasm 9421/3. • See the Non-malignant CNS Rules when the primary site is optic nerve and the diagnosis is either optic glioma or pilocytic astrocytoma.
    [Show full text]
  • A Lumbar Disc Herniation Misdiagnosed As a Neurofibromatosis Type I -A Case Report
    CASE REPORT Kor J Spine 5(3):215-218, 2008 A Lumbar Disc Herniation Misdiagnosed as A Neurofibromatosis Type I -A Case Report- Chang-hyun Oh, M.D., Hyeong-chun Park, M.D., Chong-oon Park, M.D., Seung Hwan Yoon, M.D. Department of Neurosurgery, College of Medicine, Inha University, Incheon, Korea We describe a rare case of an extradural disc herniation mimicking an extradural spinal tumor radiologically. It is often quite difficult to differentiate a sequestered disc from an extradural tumor when the discal fragments are migrated away from the origin. Distinguishable features of clinical and radiological characteristics between sequestered discs and benign intraspinal tumors were discussed. Although a well enhancing spherical mass in the spinal canal is routinely diagnosed as tumors, a free sequestered disc fragment also should be taken into consideration. This case demonstrates the role and the importance of contrast magnetic resonance imaging and of a clinical history in the diagnosis of disc herniation. Key Words: Disc herniationㆍNeurofibromatosis type IㆍMagnetic resonance imaging INTRODUCTION CASE REPORT A herniated intervertebral disc is by far the most common A 57-year-old woman was admitted to hospital having soft-tissue mass lesion within the lumbar spinal canal. In the experienced pain in the lower back and right leg for 6 absence of epidural scar, computed tomography (CT) and mag- months after the accident of slip-down from a chair. She netic resonance (MR) imaging findings of such a lesion are had MR imaging films which were taken at local hospital, typical, so that the differential diagnosis usually does not and the films showed us two mass lesions on T12 verte- exist, i.e., the disc has the same signal intensity, and the mass bral body level and L5-S1 level.
    [Show full text]
  • Primitive Neuroectodermal Tumor in the Spinal Canal: a Case Report
    1934 ONCOLOGY LETTERS 9: 1934-1936, 2015 Primitive neuroectodermal tumor in the spinal canal: A case report XIAO-TONG MENG and SHI‑SHENG HE Department of Orthopaedics, Shanghai Tenth People's Hospital Affiliated to Tongji University, Shanghai 200072, P.R. China Received May 22, 2014; Accepted January 8, 2015 DOI: 10.3892/ol.2015.2907 Abstract. Primitive neuroectodermal tumors (PNETs) are rare The present study reports the case of an otherwise healthy tumors of uncertain histogenesis that occur predominantly in 60-year-old female with extradural PNET extending into children and young adults. The current study reports a case the lumbar cavity, which caused symptoms of nerve root of PNET in a 60-year-old female, which presented clinically compression. Few such presentations have been reported as an intraspinal tumor, causing symptoms of lower back previously (6-8). Written informed consent was obtained from pain, numbness and pain in the right lower extremity. The the patient’s family. patient underwent tumorectomy. Following primary therapy, the symptoms of spinal cord compression were relieved. The Case report patient underwent several courses of radiotherapy following surgery but refused to continue with chemotherapy. After a A 60-year-old female was admitted to Shanghai Tenth further four months, the tumors recurred and the patient People's Hospital Affiliated to Tongji University (Shanghai, succumbed to the disease. China) due to a one-year history of increasing lower back pain, worsening numbness and pain on the back of the right Introduction thigh. The patient did not smoke or consume alcohol, and was suffering from diabetes, which was managed by a controlled Primitive neuroectodermal tumors (PNETs) are extremely diet.
    [Show full text]
  • Primary Tumors of the Spine
    280 Primary Tumors of the Spine Sebnem Orguc, MD1 Remide Arkun, MD1 1 Department of Radiology, Celal Bayar University, Manisa, Türkiye Address for correspondence Sebnem Orguc, MD, Department of 2 Department of Radiology, Ege University, İzmir, Türkiye Radiology, Celal Bayar University, Manisa, Türkiye (e-mail: [email protected]; [email protected]). Semin Musculoskelet Radiol 2014;18:280–299. Abstract Spinal tumors consist of a large spectrum of various histologic entities. Multiple spinal lesions frequently represent known metastatic disease or lymphoproliferative disease. In solitary lesions primary neoplasms of the spine should be considered. Primary spinal tumors may arise from the spinal cord, the surrounding leptomeninges, or the extradural soft tissues and bony structures. A wide variety of benign neoplasms can involve the spine including enostosis, osteoid osteoma, osteoblastoma, aneurysmal bone cyst, giant cell tumor, and osteochondroma. Common malignant primary neo- plasms are chordoma, chondrosarcoma, Ewing sarcoma or primitive neuroectodermal Keywords tumor, and osteosarcoma. Although plain radiographs may be useful to characterize ► spinal tumor some spinal lesions, magnetic resonance imaging is indispensable to determine the ► extradural tumor extension and the relationship with the spinal canal and nerve roots, and thus determine ► magnetic resonance the plan of management. In this article we review the characteristic imaging features of imaging extradural spinal lesions. Spinal tumors consist of a large spectrum of various histo- Benign Tumors of the Osseous Spine logic entities. Primary spinal tumors may arise from the spinal cord (intraaxial or intramedullary space), the sur- Enostosis rounding leptomeninges (intradural extramedullary space), Enostosis, also called a bone island, is a frequent benign or the extradural soft tissues and bony structures (extra- hamartomatous osseous spinal lesion with a developmental dural space).
    [Show full text]